Bulletin: USA Health Regulators Eye Artificial Intelligence in Healthcare
The FDA’s Digital Health Advisory Committee will meet in November 2024 to discuss generative AI-enabled medical devices. The meeting will focus on lifecycle considerations, safety, performance assessment, and regulation. Generative AI has shown promise in assisting medical professionals in tasks such as cancer and retinopathy detection. Concerns about reliability and potential misuse of generative AI…